Overview
Status
Active
Registry date
2014-03-20
Share capital
5,000.00 PLN
Registered address
Wawelska 40, 43-155 Bieruń, Poland
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 259 days for 2019).
- 2025not filed
- 202404/07/2025
- 202314/07/2024
- 202215/07/2023
- 202117/10/2022
- 202001/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 746.18kMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -8.52kMedianUSD 20.66kAverageUSD 86.55k
Operating costs
This companyUSD 754.62kMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 158.08kMedianUSD 544.32kAverageUSD 1.76m
Industry
Authorized Representatives
Tomasz Binert – President of the Management Board
Manner of representation
One-person management board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Beata Binertage 48 | 5 | $675.31 | 50% |
Tomasz Binertage 48 | 5 | $675.31 | 50% |
Beata Binert and Tomasz Binert hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $5,107.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,275$1,275 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,275$1,275 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 8, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Tychy |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Dolnośląska Grupa AptecznaS.A. | $30,168,188.68 | dgasa.pl | ||
| Management CompanyS.A. | $18,905,980.22 | managementcompany.pl | ||
| Grupa Aptekarska Kujałowiczsp. j. | $1,452,484.91 | wga.pl | ||
| Herbarium Świętego Franciszkasp. z o.o. | $1,397,577.12 | herbarium.katowice.pl | ||
| Eurekasp. z o.o. | $1,377,733.77 | fundacja-eureka.edu.pl | ||
| MaglowS.A. | $1,356,219.12 | maglow.pl | ||
| Farmacja Im. O. Klimuszkisp. z o.o. | $1,289,548.20 | zyj-zdrowo.com | ||
| Twoja Tania Apteka Farmarsp. z o.o. | $440,843.57 | domlekow.pl | ||
| Nukloversp. z o.o. | $227,479.26 | nuklover.com | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-WarszawaS.A. | – | farmacol.com.pl |
FAQ
The main business activity of Fitomed Pharma focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on March 20, 2014.
The headquarters is located at: Wawelska 40, 43-155 Bieruń.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $792,616, representing a decrease of 13.9% compared to 2023.
Yes, in 2024 the company was profitable, achieving a net profit of $1,665, meaning the company decreased its profit by 70.5%.
The largest operating cost category falls under employee remuneration. This category amounted to $80,636 in 2024, representing 10% of all operating expenses.
Last updated: 2026-07-16
